In the News

COVID-19's Impact on Trial Pros, Other Endpoints Can Be Addressed Via Data Stratification, Sensitivity Analysis, Clinical Trials Arena

Tuesday, June 2, 2020

Morgan Lewis partner Rebecca Dandeker was quoted in a Clinical Trials Arena article about COVID-19’s impact on patient access to clinical trials. She noted that if companies can get buy-in from a particular review division and document the conversation, that can be useful to explain protocol changes.

Read the full Clinical Trials Arena article >>